Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement
London – October 13, 2026 – Cooley advised Zealand Pharma A/S (Nasdaq: ZEAL), a biotechnology company transforming the future of metabolic health, on its collaboration and license agreement with Generate Biomedicines. Under the agreement, Generate will use its proprietary generative AI platform to lead research through lead-candidate selection and Zealand will assume responsibility for subsequent clinical development, regulatory submissions and worldwide commercialization.
Zealand will pay $30 million up-front, and up to $35 million in early preclinical milestones. Generate is eligible for total milestones of nearly $1.2 billion, including potential development, regulatory, and commercial milestones, plus tiered royalties on future worldwide net sales of any commercialized products resulting from the collaboration.
Lawyers Joe Sandys, Michael Fernando, Tanya Heare-Rowlands, Jacqueline Moore, Jack Jones, Eerik Kukebal, Rachel Thorn, Caroline Hobson and Megan Browdie led the Cooley team advising Zealand.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.
Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.
Related Contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.